Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Kjer's optic neuropathy

Diseases of the Eye and Adnexa

Kjer's optic neuropathy, also called dominant optic atrophy or autosomal dominant optic atrophy, is an inherited disease of the optic nerves that reduces visual acuity and can lead to blindness beginning in childhood. Vision loss can appear to return a second time when the early onset of presbyopia adds difficulty seeing close objects. The disease affects the retinal ganglion cells, whose axons form the optic nerve, and it results from mitochondrial dysfunction that leads to the death of optic nerve fibres, so it can be regarded as a disease of the central nervous system. It was first described clinically by Batten in 1896 and was named for the Danish ophthalmologist Poul Kjer in 1959, after he studied 19 families with the disease. It is the most common autosomally inherited optic neuropathy yet is often misdiagnosed.

Facts
Classification
Body System
Eye 1
ICD-10 Chapter
VII: Diseases of the Eye and Adnexa 1
Communicable or Non-communicable
Non-Communicable 1
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
First Described
1896 1
Sources
1. Kjer's optic neuropathy (Wikipedia)
  • Lead paragraph
    Dominant optic atrophy was first described clinically by Batten in 1896
  • Lead paragraph [body-system]
    is an autosomally inherited disease that affects the optic nerves
  • lead sentence 1
    Dominant optic atrophy (DOA), or autosomal dominant optic atrophy (ADOA), (Kjer's type) is an autosomally inherited disease that affects the optic nerves, causing reduced visual acuity and blindness beginning in childhood.
  • Lead: disease category
    Dominant optic atrophy (DOA), or autosomal dominant optic atrophy (ADOA), (Kjer's type) is an autosomally inherited disease that affects the optic nerves, causing reduced visual acuity and blindness beginning in childhood.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.